Skip to main content
. 2013 Apr 25;8(4):e62020. doi: 10.1371/journal.pone.0062020

Table 2. Sociodemographic and molecular epidemiological associations of community-associated MRSA (CA-MRSA) and healthcare-associated MRSA (HCA-MRSA) in New Zealand, 2005–2011.

Category Subcategory CA-MRSA (n = 1346) HCA CO-MRSA (n = 1132) HCA-HO-MRSA (n = 400) CA-MRSA vs. HCA CO-MRSA CA-MRSA vs. HCA HO-MRSA
P OR (95% CI) P OR (95% CI)
Age, median, years (IQR) 27 (10–47) 50 (19–78) 64 (29–80) <0.001a <0.001a
Gender Male 692 (51.4) 590 (52.1) 230 (57.5) 0.75 0.97 (0.83–1.14) 0.032 0.78 (0.62–0.99)
Female 654 (49.6) 542 (47.9) 170 (42.5)
Ethnicity European 470 (34.9) 559 (49.4) 230 (57.5) 0.001 0.8 (0.6–0.9) <0.001 0.4 (0.3–0.5)
Maori 466 (34.7) 332 (29.3) 97 (24.2) 0.005 1.3 (1.1–1.5) <0.001 1.7 (1.3–2.2)
Pacific Peoples 345 (25.6) 203 (17.9) 58 (14.5) <0.001 1.6 (1.3–1.9) <0.001 2.1 (1.5–2.8)
Other 65 (4.8) 38 (3.4) 15 (3.8) 0.07 1.5 (0.9–2.2) 0.36 1.3 (0.7–2.4)
NZDep score 1–3 (low deprivation) 158 (11.7) 171 (15.1) 70 (17.5) 0.014 0.7 (0.6–0.9) 0.003 0.6 (0.5–0.9)
4–7 (medium deprivation) 362 (26.9) 311 (27.5) 129 (32.2) 0.75 0.9 (0.8–1.2) 0.036 0.8 (0.6–1.0)
8–10 (high deprivation) 826 (61.4) 650 (57.4) 201 (50.3) 0.046 1.2 (1.0–1.4) <0.001 1.6 (1.2–2.0)
MRSA clone ST30-IV 438 (32.5) 232 (20.5) 50 (12.5) <0.001 2.2 (1.8–2.7) <0.001 3.4 (2.4–4.7)
ST5-IV 335 (24.9) 218 (19.3) 48 (12.0) 0.001 1.4 (1.1–1.7) <0.001 2.4 (1.7–3.4)
ST22-IV 87 (6.5) 282 (24.9) 154 (38.5) <0.001 0.25 (0.2–0.3) <0.001 0.1 (0.001–0.2)
ST1-IV 161 (11.9) 106 (9.4) 38 (9.5) 0.04 1.3 91.0–1.7) 0.17 1.3 (0.9–1.9)
ST8-IV 80 (5.9) 66 (5.8) 23 (5.8) 0.93 1.0 (0.7–1.5) 1.0 1.0 (0.6–1.7)
ST93-IV 64 (4.8) 33 (2.9) 9 (2.2) 0.02 1.7 (1.1–2.7) 0.03 2.2 (1.6–4.7)
ST239-III 5 (0.4) 22 (1.9) 29 (7.3) <0.001 0.2 (0.1–0.5) <0.001 0.05 (0.02–0.1)

Note: Data are number (%) of patients unless stated otherwise.

a

Mann-Whitney U test.

Abbreviations: OR, odds ratio; CI, confidence interval; IQR, interquartile range; ST, sequence type, NZDep, New Zealand Deprivation Index score; MRSA, methicillin-resistant Staphylococcus aureus.